AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 32252062
Drug: Ketamine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (0.5 mg/kg) infusion
Trial: 35471655
Drug: High-flow nasal
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-flow nasal cannula (20 l · min‐1 with 40% oxygen concentration) with head-of-bed elevation
Trial: 35471655
Drug: High-flow nasal
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-flow nasal cannula (20 l · min‐1 with 40% oxygen concentration) without head-of-bed elevation
Trial: 35471655
Drug: High-flow nasal
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-flow nasal cannula (alone or in combination with head-of-bed elevation)
Trial: 32127335
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (2000 mg docosahexaenoic acid + 400 mg eicosapentaenoic acid/day)
Trial: 32977404
Drug: Curcumin (160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curcumin (160 mg/day)
Trial: 33097947
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of fish oil and curcumin
Trial: 34666139
Drug: Antiarrhythmic drug
RxNorm normalized name: ANTIARRHYTHMICS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiarrhythmic drug (AAD) therapy
Trial: 33079154
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg of praliciguat daily for 12 weeks (n=91)
Trial: 35795714
Drug: IVIG (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVIG (400 mg/kg daily for five consecutive days starting at 4-6 weeks of gestation)
Trial: 35795714
Drug: IVIG (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVIG (400 mg/kg daily for five consecutive days starting at 4-5 weeks of gestation)
Trial: 34270930
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of Lactobacillus casei Zhang (L. casei Zhang)
Trial: 33196565
Drug: Topical eyedrops
RxNorm normalized name: sodium chloride
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical eyedrops only (Control)
Trial: 33634869
Drug: Pembrolizumab 100
RxNorm normalized name: pembrolizumab 100 MG in 4 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pembrolizumab 100 mg (Pem100)
Trial: 33634869
Drug: Pembrolizumab 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pembrolizumab 200 mg (Pem200)
Trial: 33634869
Drug: Pembrolizumab 100
RxNorm normalized name: pembrolizumab 100 MG in 4 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pembrolizumab 100 mg (Pem100) with chemotherapy
Trial: 33634869
Drug: Pembrolizumab 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pembrolizumab 200 mg (Pem200) with chemotherapy
Trial: 33634869
Drug: Cost analysis
RxNorm normalized name: Chemicals and reagents for analysis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cost analysis for Pembrolizumab 100 mg (Pem100)
Trial: 36167573
Drug: Oral co‐trimoxazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral co‐trimoxazole 960 mg once daily for 18 months
Trial: 36167573
Drug: Placebo once
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo once daily for 18 months
Trial: 35633124
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment (low molecular weight heparin and vitamin K antagonists)
Trial: 33472925
Drug: Preconditioned autologous
RxNorm normalized name: Autologous cultured fibroblasts
DrugBank: Azficel-T (DB11051)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preconditioned autologous MSC injections
Trial: 32828488
Drug: Nitric oxide
RxNorm normalized name: Nitric Oxide
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nitric oxide donors, alpha‐2‐agonists, and calcium channel blockers
Trial: 36357795
Drug: Subcutaneous octreotide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous octreotide (3 doses of 50 µg/day)
Trial: 32921989
Drug: Dexmedetomidine 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine 2 μg kg−1 (Group D)
Trial: 32921989
Drug: Dexmedetomidine 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine 2 μg kg−1 and ketamine 2 mg kg−1 (Group DK)
Trial: 32623288
Drug: Panitumumab-based treatment
RxNorm normalized name: Panitumumab
DrugBank: Panitumumab (DB01269)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Panitumumab-based treatment (induction with panitumumab-FOLFOX followed by maintenance with single-agent panitumumab)
Trial: 32623288
Drug: Single-agent panitumumab
RxNorm normalized name: Panitumumab
DrugBank: Panitumumab (DB01269)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Single-agent panitumumab (after 4-month induction with panitumumab-FOLFOX)
Trial: 37527856
Drug: Standard physical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard physical therapy (PT)
Trial: 33463020
Drug: Standard physical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard physical therapy (PT) or internet-based exercise training (IBET)
Trial: 32382926
Drug: Potassium oxalate
RxNorm normalized name: POTASSIUM OXALATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Potassium oxalate (Oxa‐Gel BF)
Trial: 32382926
Drug: Potassium oxalate
RxNorm normalized name: POTASSIUM OXALATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Potassium oxalate (Oxa‐Gel BF) associated with GaAlAs low‐power laser
Trial: 35672866
Drug: Omega-3 fish
RxNorm normalized name: Omega-3 Fish Oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega-3 fish oil (6.2 g daily)
Trial: 32464903
Drug: Intravenous iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous iron isomaltoside, 20 mg/kg
Trial: 34148021
Drug: Single antihypertensive
RxNorm normalized name: ANTIHYPERTENSIVES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single antihypertensive medication
Trial: 34148021
Drug: Multiple antihypertensive
RxNorm normalized name: ANTIHYPERTENSIVES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple antihypertensive medications
Trial: 34148021
Drug: Preferred classes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preferred classes of antihypertensive drugs
Trial: 34713983
Drug: TT+RT (testosterone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TT+RT (testosterone treatment + resistance training)
Trial: 34713983
Drug: no-TT (testosterone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: no-TT (testosterone treatment only)
Trial: 32112166
Drug: Intrathecal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal morphine with intravenous analgesia (ITM-IV)
Trial: 32112166
Drug: Intravenous analgesia
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous analgesia without intrathecal morphine (IV)
Trial: 36166405
Drug: Single high
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single high dose (10 mg/kg) of liposomal amphotericin B with optimized oral backbone of fluconazole and flucytosine
Trial: 36166405
Drug: Single high
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single high dose (10 mg/kg) of liposomal amphotericin B
Trial: 35218356
Drug: Second dose
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Second dose of measles vaccine (MV2) at 18 months of age
Trial: 35218356
Drug: Second dose
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Second dose of measles vaccine (MV2) after OPV campaigns
Trial: 35218356
Drug: Second dose
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Second dose of measles vaccine (MV2)
Trial: 35388309
Drug: Date Palm
RxNorm normalized name: date palm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Date Palm Pollen (DPP) 3 grams twice a day for two months
Trial: 36129240
Drug: Sham patch
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham patch
Trial: 33225410
Drug: Dimethyl fumarate
RxNorm normalized name: Dimethyl Fumarate
DrugBank: Dimethyl fumarate (DB08908)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dimethyl fumarate (DMF) 240 mg twice daily
Trial: 33184146
Drug: Cholecalciferol 60,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholecalciferol 60,000 IU daily for 7 days
Trial: 34803148
Drug: Glyceryl trinitrate
RxNorm normalized name: Glyceryl trinitrate
DrugBank: Nitroglycerin (DB00727)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glyceryl trinitrate ointment
Trial: 34803148
Drug: Tocopherol acetate
RxNorm normalized name: Tocopherol acetate
DrugBank: Tocopherol (DB11251)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tocopherol acetate ointment
Trial: 32950726
Drug: Photodynamic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photodynamic therapy (PDT) on dorsum of tongue
Trial: 32950726
Drug: Tongue scrappers
RxNorm normalized name: beef tongue preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tongue scrappers (TS) and adjunctive PDT
Trial: 32167679
Drug: Sacubitril–valsartan treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sacubitril–valsartan treatment
Trial: 32851572
Drug: Parenteral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral therapy
Trial: 35333880
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg moxidectin
Trial: 35333880
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg moxidectin
Trial: 35295203
Drug: TCM oral
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: TCM oral therapy combined with medicinal bath
Trial: 35295203
Drug: TCM oral
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: TCM oral therapy
Trial: 36079817
Drug: Potassium nitrate
RxNorm normalized name: Potassium Nitrate
DrugBank: Potassium (DB14500)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Potassium nitrate (10 mmol, 625 mg of nitrate)
Trial: 35932889
Drug: Immediate telephone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate telephone smoking cessation support (TSI) for 6 weeks with pharmacotherapy
Trial: 39441642
Drug: Internet-based cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-based cognitive behavioral therapy (iCBT)
Trial: 36243929
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D supplementation (50000 IU cholecalciferol weekly for three months)
Trial: 35476115
Drug: Ibuprofen (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (10 mg/kg child weight)
Trial: 34112100
Drug: Topical testosterone
RxNorm normalized name: testosterone Topical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical testosterone
Trial: 35231008
Drug: Topical estrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical estrogen
Trial: 36085409
Drug: Sub-marginal instrumentation
RxNorm normalized name: DAB(SUB 389)IL2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sub-marginal instrumentation before surgical treatment
Trial: 34246761
Drug: Full-treatment group
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full-treatment group (8 weeks of binocular treatment using therapeutic software application in virtual reality headset)
Trial: 34246761
Drug: Sham-crossover group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham-crossover group (4 weeks of sham treatment followed by 4 weeks of binocular treatment)
Trial: 34246761
Drug: Full-treatment group
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full-treatment group
Trial: 35956935
Drug: NanoBEO (essential
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NanoBEO (essential oil of bergamot) administered as a single therapeutic dose via an airless dispenser.
Trial: 34785535
Drug: No fenofibrate
RxNorm normalized name: Fenofibrate
DrugBank: Fenofibrate (DB01039)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No fenofibrate therapy
Trial: 32404062
Drug: Probiotics administered
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotics administered twice daily during antibiotic treatment for up to 1 week after completion of antibiotics
Trial: 35121932
Drug: Flt3 ligand
RxNorm normalized name: Allogeneic natural killer (NK) cells derived from CD34+ human placental stem/progenitor cells. The cells are expanded and differentiated in the presence of cytokines including thrombopoietin, SCF, Flt3 ligand, IL-7, IL-15 and IL-2 to generate the NK cell
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flt3 ligand (CDX-301) pre-treatment with anti-DEC-205-NY-ESO-1 vaccine
Trial: 35121932
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (anti-DEC-205-NY-ESO-1 vaccine without Flt3 ligand)
Trial: 34032900
Drug: High protein
RxNorm normalized name: Vital High Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High protein intake (> 2.1 g protein/kg lean body mass/day)
Trial: 34032900
Drug: Recommended protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recommended protein intake (1.1 g protein/kg lean body mass/day)
Trial: 34067261
Drug: Cobalt‐chrome‐based metal‐ceramic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cobalt‐chrome‐based metal‐ceramic prostheses using CAD/CAM (CC‐MC)
Trial: 34067261
Drug: Zirconia‐based ceramic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zirconia‐based ceramic prostheses using CAD/CAM (CC‐Zr)
Trial: 34067261
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (MC, CC‐MC, CC‐Zr)
Trial: 35316121
Drug: treatment-as-usual (TAU)
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: treatment-as-usual (TAU) group
Trial: 32529966
Drug: Psychedelic-assisted therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychedelic-assisted therapy (psilocybin, LSD, ayahuasca, MDMA)
Trial: 36100930
Drug: Hyperbaric oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperbaric oxygen treatment (HBOT) - 90 min at 203 kPa daily for 20 days
Trial: 35731065
Drug: Selected physical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selected physical therapy program only (Control group)
Trial: 34480773
Drug: Five-session online
RxNorm normalized name: fivehorn smotherweed pollen extract
DrugBank: Bassia hyssopifolia pollen (DB10941)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Five-session online imaginal exposure therapy (n=65)
Trial: 34570916
Drug: Semaglutide 0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Semaglutide 0.4 mg once-daily subcutaneous
Trial: 35306553
Drug: Mesalazine treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mesalazine treatment
Trial: 35212023
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg oral estradiol
Trial: 33765420
Drug: Vitamin K
RxNorm normalized name: Vitamin K
DrugBank: Phylloquinone (DB01022)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin K antagonist (phenprocoumon, acenocoumarol, or warfarin; target INR 2.0-3.0) for 90 days
Trial: 35656931
Drug: Vitamin K
RxNorm normalized name: Vitamin K
DrugBank: Phylloquinone (DB01022)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin K antagonist
Trial: 35394123
Drug: 250-mg azithromycin
RxNorm normalized name: azithromycin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250-mg azithromycin test formulation
Trial: 35394123
Drug: 250-mg azithromycin
RxNorm normalized name: azithromycin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250-mg azithromycin reference formulation
Trial: 34819147
Drug: Low-dose calcium
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose calcium supplementation (500 mg elemental calcium/day)
Trial: 34819147
Drug: Standard high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard high-dose calcium supplementation (1500 mg elemental calcium/day)
Trial: 33709626
Drug: ModraDoc006/r 30-20/100-100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ModraDoc006/r 30-20/100-100 (30 mg once weekly with ritonavir 100 mg in the morning, and 20 mg with ritonavir 100 mg in the evening)
Trial: 32212800
Drug: m-DCF regimen
RxNorm normalized name: Anacin Aspirin Regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: m-DCF regimen (docetaxel 40 mg/m2, cisplatin 40 mg/m2, 5-fluorouracil 400 mg/m2)
Trial: 32212800
Drug: EOX regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EOX regimen (epirubicin 50 mg/m2, oxaliplatin 130 mg/m2, capecitabine 625 mg/m2)
Trial: 34583675
Drug: CRP ≤
RxNorm normalized name: C-reactive protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CRP ≤ 22 mg/L combined with rhinorrhea
Trial: 34583675
Drug: PCT ≤
RxNorm normalized name: Paracetamol
DrugBank: Acetaminophen (DB00316)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PCT ≤ 0.18 ng/mL combined with rhinorrhea
Trial: 34583675
Drug: CRP ≤
RxNorm normalized name: C-reactive protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CRP ≤ 22 mg/L and PCT ≤ 0.18 ng/mL combined with rhinorrhea
Trial: 35288387
Drug: Current intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Current intravenous fluid care
Trial: 35933415
Drug: Cannabidiol (CBD)
RxNorm normalized name: cannabidiol (CBD)
DrugBank: Cannabidiol (DB09061)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Cannabidiol (CBD) 150 mg oil twice daily (300 mg daily) for 8 days before chemotherapy
Trial: 34147245
Drug: Neuromuscular block
RxNorm normalized name: Neuromuscular blocking agent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neuromuscular block using rocuronium (mean dose 12.7 mg, 0.7 mg kg−1)
Trial: 34826148
Drug: Oral fexofenadine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral fexofenadine combined with topical treatment (topical tacrolimus 0.03–0.1% ointment once daily, topical fluticasone propionate 0.05% cream once daily, paraffin‐based emollients) for 8 weeks
Trial: 34826148
Drug: Topical treatment
RxNorm normalized name: Hongo Killer Treatment Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical treatment only (topical tacrolimus 0.03–0.1% ointment once daily, topical fluticasone propionate 0.05% cream once daily, paraffin‐based emollients) for 8 weeks
Trial: 34203924
Drug: Therapies with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapies with transference interpretations
Trial: 34203924
Drug: Therapies without
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapies without transference interpretations
Trial: 32988624
Drug: Olaparib (300mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olaparib (300mg oral tablets, twice daily for 28 days)
Trial: 35692186
Drug: THC (13-49
FDA approved: no
EMA approved: no
PMDA approved: no
Description: THC (13-49 mg)
Trial: 35896910
Drug: Reminiscence therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reminiscence therapy plus usual care (RTUC)
Trial: 35314257
Drug: Empagliflozin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empagliflozin (10 mg or 25 mg)
Trial: 36198292
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of TRE and HIIT (TREHIIT)
Trial: 34776146
Drug: Multicomponent exercise
RxNorm normalized name: meningococcus B, multicomponent vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multicomponent exercise program (MCEP) performed twice weekly for two months
Trial: 32852574
Drug: Duloxetine (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine (40 mg BID) + innovative pelvic floor muscle training (iPFMT)
Trial: 34050197
Drug: Dose 1
RxNorm normalized name: Aldose 1-epimerase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose 1 Curry (D1C) - 6g mixed spices
Trial: 34050197
Drug: Dose 2
RxNorm normalized name: Fluzone High-Dose 2011-2012
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose 2 Curry (D2C) - 12g mixed spices
Trial: 34050197
Drug: Dose 0
RxNorm normalized name: Femhrt Low Dose 0.5/2.5 Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose 0 Control (D0C) - low-polyphenol, no spices
Trial: 36242060
Drug: Whole brain
RxNorm normalized name: pork brain preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole brain radiation therapy for synchronous brain metastases with irradiation protecting the hippocampus
Trial: 36242060
Drug: Whole brain
RxNorm normalized name: pork brain preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole brain radiotherapy for sequential brain metastases to boost irradiation
Trial: 32900266
Drug: Acute ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acute ketamine dosing